ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,361Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 1942

$558K Total Retail Price of All Prescriptions

Rank: 54 out of 1942

334 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 11,794 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
AMLODIPINE BESYLATE 647 642 1 6
CRESTOR 622 598 2 34
LISINOPRIL 557 508 3 2
SIMVASTATIN 547 536 4 1
OMEPRAZOLE 452 435 5 4
METOPROLOL SUCCINATE 316 311 6 13
ZOLPIDEM TARTRATE 313 286 7 25
PRAVASTATIN SODIUM 305 285 8 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 284 271 9 22
METOPROLOL TARTRATE 227 189 10 9
DIOVAN 213 211 11 44
ASPIRIN EC 211 211 12 92
METFORMIN HCL ER 190 189 13 46
LANSOPRAZOLE 188 186 14 125
LEVOTHYROXINE SODIUM 185 176 15 3
LOSARTAN POTASSIUM 183 171 16 18
WARFARIN SODIUM 177 177 17 11
ATENOLOL 175 162 18 7
FUROSEMIDE 168 156 19 5
ATORVASTATIN CALCIUM 163 158 20 14
METFORMIN HCL 157 151 21 10
TRAMADOL HCL 153 143 22 19
DIOVAN HCT 151 151 23 114
DONEPEZIL HCL 145 145 24 30
POLYETHYLENE GLYCOL 3350 143 142 25 28
CITALOPRAM HBR 134 134 26 15
HYDROCHLOROTHIAZIDE 128 120 27 8
GABAPENTIN 125 121 28 16
LIPITOR 125 125 28 147
GLIPIZIDE XL 122 122 30 109
CHLORTHALIDONE 121 121 31 76
LOSARTAN-HYDROCHLOROTHIAZIDE 118 118 32 67
TAMSULOSIN HCL 113 109 33 29
VITAMIN D 107 104 34 150
JANUVIA 107 107 34 85
TERAZOSIN HCL 99 99 36 77
MECLIZINE HCL 93 92 37 190
PLAVIX 91 87 38 83
CLONIDINE HCL 90 90 39 100
POTASSIUM CHLORIDE 88 88 40 17
SINGLE USE SWAB 86 86 41 200
RANITIDINE HCL 81 80 42 31
GLIPIZIDE 80 80 43 63
ISOSORBIDE MONONITRATE ER 77 77 44 42
NITROSTAT 77 75 44 203
TRIAMTERENE-HCTZ 73 73 46 36
ALLOPURINOL 72 72 47 26
PROAIR HFA 65 62 48 41
ATENOLOL-CHLORTHALIDONE 64 64 49 115
SERTRALINE HCL 63 63 50 20
CLOPIDOGREL 61 61 51 55
GLIPIZIDE ER 60 60 52 80
SPIRONOLACTONE 60 60 52 59
CARVEDILOL 60 53 52 39
HYDROCODONE-ACETAMINOPHEN 58 54 S3 55 12
TIZANIDINE HCL 57 57 56 160
SENNA 51 51 57 270
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.